ALBA CASCO: Open Payments
NPI 1689066490 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$408 in 9 payments from 7 companies in 2025. Trend: 2023 $271 · 2024 $15 · 2025 $408
Food & beverage: $408
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $158 |
| Madrigal Pharmaceuticals | 1 | $126 |
| Novo Nordisk Inc | 2 | $57 |
| Seqirus USA Inc | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
| Cranial Technologies, Inc | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $16 |
Products named: XIFAXAN, REZDIFFRA, Wegovy, Flucelvax, MAVYRET, Doc Band, ROTATEQ.
Industry payments across CA — which companies pay providers there.
